| 2024-06-25 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Commercial Officer | 1,605 0.0012% | $231.00 | $370,747 | +6.14% | |
| 2024-02-28 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Commercial Officer | 501 0.0004% | $155.30 | $77,805 | -3.37% | |
| 2024-02-16 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Commercial Officer | 1,009 0.0008% | $148.06 | $149,397 | +2.09% | |
| 2023-04-27 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Commercial Officer | 1,476 0.0012% | $194.59 | $287,215 | -8.05% | |
| 2023-02-03 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Commercial Officer | 3,424 0.0027% | $232.14 | $794,854 | -18.52% | |
| 2023-02-02 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Commercial Officer | 1,601 0.0013% | $226.01 | $361,839 | -17.23% | |
| 2022-08-03 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Commercial Officer | 105 <0.0001% | $220.95 | $23,200 | -3.41% | |
| 2022-07-05 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Commercial Officer | 1,754 0.0014% | $150.00 | $263,100 | +35.68% |